Coronary Atherosclerotic Plaque Burden Assessment by Computed Tomography and Its Clinical Implications
Nishant VatsaChristian Faaborg-AndersenTiffany DongMichael J. BlahaLeslee J. ShawRaymundo A. QuintanaDepartment of Medicine,Division of Cardiology,Emory University School of Medicine,Atlanta,GA (N.V.).Department of Internal Medicine,Massachusetts General Hospital/Harvard Medical School,Boston (C.F.-A.).Section of Cardiovascular Imaging,Department of Cardiovascular Medicine,Heart,Vascular,and Thoracic Institute,Cleveland Clinic,OH (T.D.).The Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease,Baltimore,MD (M.J.B.).Blavatnik Family Research Institute,Icahn School of Medicine at Mount Sinai,New York,NY (L.J.S.).Cardiovascular Imaging Section,Division of Cardiology,University of Colorado Anschutz Medical Campus,Aurora (R.A.Q.).
DOI: https://doi.org/10.1161/circimaging.123.016443
2024-08-22
Circulation Cardiovascular Imaging
Abstract:Circulation: Cardiovascular Imaging, Volume 17, Issue 8, Page e016443, August 1, 2024. Recent studies have demonstrated that coronary plaque burden carries greater prognostic value in predicting adverse atherosclerotic cardiovascular disease outcomes than myocardial ischemia, thereby challenging the existing paradigm. Advances in plaque quantification through both noncontrast and contrast-enhanced computed tomography (CT) methods have led to earlier and more cost-effective detection of coronary disease compared with traditional stress testing. The 2 principal techniques of noninvasive coronary plaque quantification assessment are coronary artery calcium scoring by noncontrast CT and coronary CT angiography, both of which correlate with disease burden on invasive angiography. Plaque quantification from these imaging modalities has shown utility in risk stratification and prognostication of adverse cardiovascular events, leading to increased incorporation into clinical practice guidelines and preventive care pathways. Furthermore, due to their expanding clinical value, emerging technologies such as artificial intelligence are being integrated into plaque quantification platforms, placing more advanced measures of plaque burden at the forefront of coronary plaque evaluation. In this review, we summarize recent clinical data on coronary artery calcium scoring and coronary CT angiography plaque quantification in the evaluation of adverse atherosclerotic cardiovascular disease in patients with and without chest pain, highlight how these methods compare to invasive quantification approaches, and directly compare the performance characteristics of coronary artery calcium scoring and coronary CT angiography.
radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems